i-STRONGER for Functional Recovery in Aging
Trial Summary
What is the purpose of this trial?
This cluster randomized clinical trial seeks to provide large-scale, foundational evidence that high-intensity rehabilitation is effective and can be systematically implemented to improve functional outcomes for patients admitted to skilled nursing facilities following hospitalization. Additionally, this study will generate a descriptive overview of factors that predict implementation success while informing effective implementation strategies for future skilled nursing facilities innovation.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the i-STRONGER treatment for functional recovery in aging?
A high-intensity resistance training approach like i-STRONGER has shown better physical function in older adults in skilled nursing facilities, according to a single-site pilot study. This suggests that more intense rehabilitation can lead to improved outcomes compared to standard low-intensity care.12345
Is the i-STRONGER rehabilitation program safe for older adults in skilled nursing facilities?
The i-STRONGER program, which involves high-intensity resistance training, has been studied for its safety and feasibility in skilled nursing facilities. While high-intensity training can improve physical function, it is important to monitor for potential adverse events, such as falls, which are common among older adults in these settings.34678
How is the i-STRONGER treatment different from other treatments for functional recovery in aging?
The i-STRONGER treatment is unique because it uses high-intensity resistance training specifically designed to challenge skeletal muscles, which is different from the low-intensity interventions typically used in skilled nursing facilities. This approach has shown better physical function improvements in older adults compared to standard care.346910
Research Team
Jennifer E Stevens-Lapsley, PT, PhD
Principal Investigator
University of Colorado, Denver
Eligibility Criteria
This trial is for adults aged 50 or older who can walk when they enter a skilled nursing facility (SNF) from the hospital. They must be in an SNF that works with Aegis Therapies and sees about 15 patients a month for short-term rehab. People with weight-bearing issues, multiple SNF stays, contraindications to intense exercise, or neurological conditions like stroke or Parkinson's cannot join.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive high-intensity rehabilitation (i-STRONGER) or usual care in skilled nursing facilities
Follow-up
Participants are monitored for safety and effectiveness after treatment, including rehospitalization rates
Implementation Evaluation
Evaluation of the implementation success of high-intensity rehabilitation using the RE-AIM framework
Treatment Details
Interventions
- i-STRONGER (Behavioural Intervention)
- Usual Care (Other)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor
Aviva Abosch
University of Colorado, Denver
Chief Medical Officer since 2019
MD
Uday B. Kompella
University of Colorado, Denver
Chief Executive Officer since 2015
PhD in Pharmaceutical Sciences
Aegis Therapies, Inc.
Collaborator
National Institute on Aging (NIA)
Collaborator
Dr. Richard J. Hodes
National Institute on Aging (NIA)
Chief Executive Officer since 1993
MD from Harvard Medical School
Dr. Marie Bernard
National Institute on Aging (NIA)
Chief Medical Officer
MD from Harvard Medical School